Pharmacogenomics of MDR1/ABCB1 gene: The influence on risk and clinical outcome of haemotological malignancies

Hematology

Volumn 9, Issue 2, 2004, Pages 91-105

  Jamroziak, Krzysztof ^a   Robak, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

ABCB1; MDR1; P glycoprotein; Polymorphism

Indexed keywords

ABC TRANSPORTER; AMSACRINE; ANTINEOPLASTIC AGENT; COLCHICINE; CYCLOSPORIN A; DACTINOMYCIN; DAUNORUBICIN; DEXAMETHASONE; DOCETAXEL; DOXORUBICIN; ELACRIDAR; EPIRUBICIN; ETOPOSIDE; GLYCOPROTEIN P; HYDROCORTISONE; IRINOTECAN; MITHRAMYCIN; MITOMYCIN C; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; PREDNISONE; PUROMYCIN; TAMOXIFEN; TENIPOSIDE; TOPOTECAN; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; VINDESINE;

ALLELE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; DRUG TRANSPORT; ETHNIC DIFFERENCE; EXON; GASTROINTESTINAL ABSORPTION; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENETIC CODE; GENETIC PREDISPOSITION; HAPLOTYPE; HEMATOLOGIC MALIGNANCY; HUMAN; KAPLAN MEIER METHOD; PHARMACOGENOMICS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE DISTRIBUTION;

EID: 2542622040     PISSN: 10245332     EISSN: None     Source Type: Journal    
DOI: 10.1080/10245330310001638974     Document Type: Review

References (108)

1. Evans, W.E. and McLeod, H.L. (2003) "Pharmacogenomics-drug disposition, drug targets, and side effects", N. Engl. J. Med. 348, 538-549.
2. Voso, M.T., D'Alo', F., Putzulu, R., Mele, L., Scardocci, A., Chiusolo, P., Latagliata, R., Lo-Coco, F., Rutella, S., Pagano, L., Hohaus, S. and Leone, G. (2002) "Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia", Blood 100, 2703-2707.
3. Dean, M., Rzhetsky, A. and Allikmets, R. (2001) "The human ATP-binding cassette (ABC) transporter superfamily", Genome Res. 11, 1156-1166.
4. Juliano, R.L. and Ling, V. (1976) "A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants", Biochim. Biophys. Acta 455, 152-162.
5. Goldstein, L.J., Galski, H., Fojo, A., Willingham, M., Lai, S.L., Gazdar, A., Pirker, R., Green, A., Crist, W. and Brodeur, G.M. (1989) "Expression of a multidrug resistance gene in human cancers", J. Natl Cancer Inst. 81, 116-124.
6. Ambdukar, S.V., Dey, S., Hrycyna, C.A., Ramachandra, M., Pastan, I. and Gottesman, M.M. (1999) "Biochemical, cellular, and pharmacological aspects of the multidrug transporter", Annu. Rev. Pharmacol. Toxicol. 39, 361-398.
7. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M.M., Pastan, I. and Willingham, M.C. (1987) "Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues", Proc. Natl Acad. Sci. USA 84, 7735-7738.
8. Klimecki, W.T., Futscher, B.W., Grogan, T.M. and Dalton, W.S. (1994) "P-glycoprotein expression and function in circulating blood cells from normal volunteers", Blood 83, 2451-2458.
9. Ford, J.M. and Hait, W.N. (1990) "Pharmacology of drugs that alter multidrug resistance in cancer", Pharmacol. Rev. 42, 155-199.
10. Higgins, C.F. and Gottesman, M.M. (1992) "Is the multidrug transporter a flippase?", Trends Biochem. Sci. 17, 18-21.
11. Bolhuis, H., van Veen, H.W., Molenaar, D., Poolman, B., Driessen, A.J. and Konings, W.N. (1996) "Multidrug resistance in Lactococcus lactis: evidence for ATP-dependent drug extrusion from the inner leaflet of the cytoplasmic membrane", EMBO J. 15, 4239-4245.
12. Hoffman, M.M. and Roepe, P.D. (1997) "Analysis of ion transport perturbations caused by hu MDR 1 protein overexpression", Biochemistry 36, 11153-11168.
13. Penny, J.I. and Campbell, F.C. (1994) "Active transport of benzo[a]pyrene in apical membrane vesicles from normal human intestinal epithelium", Biochim. Biophys. Acta 1226, 232-236.
14. Walle, K.U. and Walle, T. (1999) "Transport of the cook-food mutagen 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) across the human intestinal Caco-2 cell monolayer: role of efflux pumps", Carcinogenesis 20, 2153-2157.
15. Mochida, Y., Taguchi, K., Taniguchi, S., Tsuneyoshi, M., Kuwano, H., Tsuzuki, T., Kuwano, M. and Wada, M. (2003) "The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in Apc(Min/+) mice", Carcinogenesis 24, 1219-1224.
16. Smyth, M.J., Krasovskis, E., Sutton, V.R. and Johnstone, R.W. (1998) "The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis", Proc. Natl Acad. Sci. USA 95, 7024-7029.
17. Gollapud, S. and Gupta, S. (2001) "Anti-P-glycoprotein antibody-induced apoptosis of activated peripheral blood lymphocytes: a possible role of P-glycoprotein in lymphocyte survival", J. Clin. Immunol. 21, 420-430.
18. Drach, J., Gsur, A., Hamilton, G., Zhao, S., Angerler, J., Fiegl, M., Zojer, N., Raderer, M., Haberl, I., Andreeff, M. and Huber, H. (1996) "Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes", Blood 88, 1747-1754.
19. Randolph, G.J., Beaulieu, S., Pope, M., Sugawara, I., Hoffman, L., Steinman, R.M. and Muller, W.A. (1998) "A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels", Proc. Natl Acad. Sci. USA 95, 6924-6929.
20. Bunting, K.D. (2002) "ABC transporters as phenotypic markers and functional regulators of stem cells", Stem. Cells 20, 11-20.
21. Schinkel, A.H., Mayer, U., Wagenaar, E., Mol, C.A., van Deemter, L., Smit, J.J., van der Valk, M.A., Voordouw, A.C., Spits, H., van Tellingen, O., Zijlmans, J.M., Fibbe, W.E. and Borst, P. (1997) "Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins", Proc. Natl Acad. Sci. USA 94, 4028-4033.
22. Meerum Terwogt, J.M., Beijnen, J.H., ten Bokkel Huinink, W.W., Rosing, H. and Schellens, J.H. (1998) "Co-administration of cyclosporin enables oral therapy with paclitaxel", Lancet 352, 285.
23. Malingre, M.M., Beijnen, J.H., Rosing, H., Koopman, F.J., Jewell, R.C., Paul, E.M., Ten Bokkel Huinink, W.W. and Schellens, J.H. (2001) "Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients", Br. J. Cancer 84, 42-47.
24. Taipalensuu, J., Tornblom, H., Lindberg, G., Einarsson, C., Sjoqvist, F., Melhus, H., Garberg, P., Sjostrom, B., Lundgren, B. and Artursson, P. (2001) "Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers", J. Pharmacol. Exp. Ther. 299, 164-170.
25. Tran, C.D., Timmins, P., Conway, B.R. and Irwin, W.J. (2002) "Investigation of the coordinated functional activities of cytochrome P450 3A4 and P-glycoprotein in limiting the absorption of xenobiotics in Caco-2 cells", J. Pharm. Sci. 91, 117-128.
26. Pallis, M. and Russell, N. (2000) "P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway", Blood 95, 2897-2904.
27. Jamroziak, K., Smolewski, P., Balcerczak, E., Cebula, B., Panczyk, M., Szmigielska-Kaplon, A., Mirowski, M. and Robak, T. (2003) "Relation of P-glycoprotein expression, activity and MDR1 gene polymorphism with spontaneous in vitro apoptosis in B-cell chronic lymphocytic leukaemia", Hematol. J. 4(Suppl. 2), 192.
28. Hotta, T., Tanimura, H., Iwahashi, M., Tani, M., Tsunoda, T., Noguchi, K., Mizobata, S., Arii, K., Terasawa, H., Nakamori, M. and Yamaue, H. (1999) "P-glycoprotein-expressing tumor cells are resistant to anticancer drugs in human gastrointestinal cancer", Surg. Today 29, 591-596.
29. Ferguson, P.J. and Cheng, Y.C. (1989) "Phenotypic instability of drug sensitivity in a human colon carcinoma cell line", Cancer Res. 49, 1148-1153.
30. Marie, J.P. (2001) "Drug resistance in hematologic malignancies", Curr. Opin. Oncol. 13, 463-469.
31. Hirose, M. (2002) "Biology and modulation of multidrug resistance (MDR) in hematological malignancies", Int. J. Hematol. 76(Suppl. 2), 206-211.
32. Leith, C.P., Kopecky, K.J., Chen, I.M., Eijdems, L., Slovak, M.L., McConnell, T.S., Head, D.R., Weick, J., Grever, M.R., Appelbaum, F.R. and Willman, C.L. (1999) "Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study", Blood 94, 1086-1099.
33. Illmer, T., Shuler, U.S., Thiede, C., Schwarz, U.I., Kim, R.B., Gothard, S., Freund, D., Schakel, U., Ehninger, G. and Shaich, M. (2002) "MDR gene polymorphisms affect therapy outcome in acute myeloid leukemia patients", Cancer Res. 62, 4955-4962.
34. Leith, C.P., Kopecky, K.J., Godwin, J., McConnell, T., Slovak, M.L., Chen, I.M., Head, D.R., Appelbaum, F.R. and Willman, C.L. (1997) "Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study", Blood 89, 3323-3329.
35. Broxterman, H.J., Sonneveld, P., van Putten, W.J., Lankelma, J., Eekman, C.A., Ossenkoppele, G.J., Pinedo, H.M., Lowenberg, B. and Schuurhuis, G.J. (2000) "P-glycoprotein in primary acute myeloid leukemia and treatment outcome of idarubicin/cytosine arabinoside-based induction therapy", Leukemia 14, 1018-1024.
36. GIMEMA Group, Tafuri, A., Gregorj, C., Petrucci, M.T., Ricciardi, M.R., Mancini, M., Cimino, G., Mecucci, C., Tedeschi, A., Fioritoni, G., Ferrara, F., Di Raimondo, F., Gallo, E., Liso, V., Fabbiano, F., Cascavilla, N., Pizzolo, G., Camera, A., Pane, F., Lanza, F., Cilloni, D., Annino, L., Vitale, A., Vegna, M.L., Vignetti, M., Foa, R. and Mandelli, F. (2002) "MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia", Blood 100, 974-981.
37. Wattel, E., Lepelley, P., Merlat, A., Sartiaux, C., Bauters, F., Jouet, J.P. and Fenaux, P. (1995) "Expression of the multidrug resistance P glycoprotein in newly diagnosed adult acute lymphoblastic leukemia: absence of correlation with response to treatment", Leukemia 9, 1870-1874.
38. Baer, M.R., George, S.L., Dodge, R.K., O'Loughlin, K.L., Minderman, H., Caligiuri, M.A., Anastasi, J., Powell, B.L., Kolitz, J.E., Schiffer, C.A., Bloomfield, C.D. and Larson, R.A. (2002) "Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720", Blood 100, 1224-1232.
39. Ueda, K., Clark, D.P., Chen, C., Roninson, I.B., Gottesman, M.M. and Pastan, I. (1987) "The human multidrug resistance (mdr1) gene", J. Biol. Chem. 262, 505-508.
40. Chen, C., Clark, D., Ueda, K., Pastan, I., Gottesman, M.M. and Roninson, I.B. (1990) "Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins", J. Biol. Chem. 506, 514.
41. Ruetz, S. and Gros, P. (1994) "Phosphatidylcholine translocase: a physiological role for the mdr2 gene", Cell 77, 1071-1081.
42. Croop, J.M., Raymond, M., Haber, D., Devault, A., Arceci, R.J., Gros, P. and Housman, D.E. (1989) "The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues", Mol. Cell Biol. 9, 1346-1350.
43. Kantharidis, P., El-Osta, S., Silva, M., Lee, G., Hu, X.F. and Zalcberg, J. (2000) "Regulation of MDR1 gene expression: emerging concepts", Drug Resist. Updat. 3, 99-108.
44. Yoshimoto, K., Iwahana, H., Yokogoshi, Y., Saito, S., Shiraishi, M., Sekiya, T., Gottesman, M.M. and Pastan, I. (1988) "A polymorphic HindIII site within the human multidrug resistance gene 1 (MDR1)", Nucleic Acids Res. 16, 11850.
45. Kioka, N., Tsubota, J., Kakehi, Y., Komano, T., Gottesman, M.M., Pastan, I. and Ueda, K. (1989) "P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance", Biochem. Biophys. Res. Commun. 162, 224-231.
46. Stein, U., Walther, W. and Wunderlich, V. (1994) "Point mutations in the mdr1 promoter of human osteosarcomas are associated with in vitro responsiveness to multidrug resistance relevant drugs", Eur. J. Cancer 30A, 1541-1545.
47. Mickley, L.A., Lee, J.S., Weng, Z., Zhan, Z., Alvarez, M., Wilson, W., Bates, S.E. and Fojo, T. (1998) "Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors", Blood 91, 1749-1756.
48. Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H.P., Brockmoller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M. and Brinkmann, U. (2000) "Functional polymorphisms of the human multidrug resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo", Proc. Natl Acad. Sci. USA 97, 3473-3478.
49. Decleves, X., Chevillard, S., Charpentier, C., Vielh, P. and Laplanche, J.L. (2000) "A new polymorphism (N21D) in the exon 2 of the human MDR1 gene encoding the P-glycoprotein", Hum. Mutat. 15, 486.
50. Kim, R.B., Leake, B.F., Choo, E.F., Dresser, G.K., Kubba, S.V., Schwarz, U.I., Taylor, A., Xie, H.G., McKinsey, J., Zhou, S., Lan, L.B., Schuetz, J.D., Schuetz, E.G. and Wilkinson, G.R. (2001) "Identification of functionally variant MDR1 alleles among European Americans and African Americans", Clin. Pharmacol. Ther. 70, 189-199.
51. Ito, S., Ieiri, I., Tanabe, M., Suzuki, A., Higuchi, S. and Otsubo, K. (2001) "Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT in healthy Japanese subjects", Pharmacogenetics 11, 175-184.
52. Tanabe, M., Ieiri, I., Nagata, N., Inoue, K., Ito, S., Kanamori, Y., Takahashi, M., Kurata, Y., Kigawa, Y., Higuchi, S., Terakawa, N. and Otsubo, K. (2001) "Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene", J. Pharmacol. Exp. Ther. 297, 1137-1143.
53. Kroetz, D.L., Pauli-Magnus, C., Hodges, L.M., Huang, C.C., Kawamoto, M., Johns, S.J., Stryke, D., Ferrin, T.E., DeYoung, J., Taylor, T., Carlson, E.J., Herskowitz, I., Giacomini, K.M. and Clark, A.G. (2003) "Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene", Pharmacogenetics 13, 481-494.
54. Moriya, Y., Nakamura, T., Horinouchi, M., Sakaeda, T., Tamura, T., Aoyama, N., Shirakawa, T., Gotoh, A., Fujimoto, S., Matsuo, M., Kasuga, M. and Okumura, K. (2002) "Effects of polymorphisms of MDR1, MRP1, and MRP2 genes on their mRNA expression levels in duodenal enterocytes of healthy Japanese subjects", Biol. Pharm. Bull. 25, 1356-1359.
55. Riva, A. and Kohane, I.S. (2002) "SNPper: retrieval and analysis of human SNPs", Bioinformatics 18, 1681-1685.
56. Zheng, H., Webber, S., Zeevi, A., Schuetz, E., Zhang, J., Lamba, J., Bowman, P. and Burckart, G.J. (2002) "The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in paediatric heart transplant patients", Hum. Immunol. 63, 765-770.
57. Horinouchi, M., Sakaeda, T., Nakamura, T., Morita, Y., Tamura, T., Aoyama, N., Kasuga, M. and Okumura, K. (2002) " Significant genetic linkage of MDR1 polymorphisms at positions 3435 and 2677: functional relevance to pharmacogenetics of digoxin", Pharm. Res. 19, 1581-1585.
58. Tang, K., Ngoi, S.M., Gwee, P.C., Chua, J.M., Lee, E.J., Chong, S.S. and Lee, C.G. (2002) "Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations", Pharmacogenetics 12, 437-450.
59. Siddiqui, A., Kerb, R., Weale, M.E., Brinkmann, U., Smith, A., Goldstein, D.B., Wood, N.W. and Sisodiya, S.M. (2003) " Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1", N. Engl. J. Med. 348, 1442-1448.
60. Ameyaw, M.M., Regateiro, F., Li, T., Liu, X., Tariq, M., Mobarek, A., Thornton, N., Folayan, G.O., Githang'a, J., Indalo, A., Ofori-Adjei, D., Price-Evans, D.A. and McLeod, H.L. (2001) "MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity", Pharmacogenetics 11, 217-221.
61. Cascorbi, I., Gerloff, T., Johne, A., Meisel, C., Hoffmeyer, S., Schwab, M., Schaeffeler, E., Eichelbaum, M., Brinkmann, U. and Roots, I. (2001) "Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects", Clin. Pharmacol. Ther. 69, 169-174.
62. Jamroziak, K., Balcerczak, E., Mlynarski, W., Mirowski, M. and Robak, T. (2002) "Distribution of allelic variants of functional C3435T polymorphism of drug transporter MDR1 gene in a sample of Polish population", Pol. J. Pharmacol. 54, 495-500.
63. Bernal, M.L., Sinues, B., Fanlo, A. and Mayayo, E. (2003) "Frequency distribution of C3435T mutation in exon 26 of the MDR1 gene in a Spanish population", Ther. Drug Monit. 25, 107-111.
64. Balram, C., Sharma, A., Sivathasan, C. and Lee, E.J. (2003) "Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic-genotypic correlates", Br. J. Clin. Pharmacol. 56, 78-83.
65. Schaeffeler, E., Eichelbaum, M., Brinkmann, U., Penger, A., Asante-Poku, S., Zanger, U.M. and Schwab, M. (2001) "Frequency of C3435T polymorphism of MDR1 gene in African people", Lancet 358, 383-384.
66. Walters, T.R., Bushore, M. and Simone, J. (1972) "Poor prognosis in Negro children with acute lymphoblastic leukaemia", Cancer 29, 210-214.
67. Jamroziak, K., Mlynarski, W., Balcerczak, E., Mistygacz, M., Trelinska, J., Mirowski, M., Bodalski, J. and Robak, T. (2003) "Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia", Eur. J. Hematol., (in press).
68. Hitzl, M., Drescher, S., van der Kuip, H., Schaffeler, E., Fischer, J., Schwab, M., Eichelbaum, M. and Fromm, M.F. (2001) "The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells", Pharmacogenetics 11, 293-298.
69. Oselin, K., Gerloff, T., Mrozikiewicz, P.M., Pahkla, R. and Roots, I. (2003) "MDR1 polymorphisms G2677T in exon 21 and C3435T in exon 26 fail to affect rhodamine 123 efflux in peripheral blood lymphocytes", Fundam. Clin. Pharmacol. 17, 463-469.
70. Fellay, J., Marzolini, C., Meaden, E.R., Back, D.J., Buclin, T., Chave, J.P., Decosterd, L.A., Furrer, H., Opravil, M., Pantaleo, G., Retelska, D., Ruiz, L., Schinkel, A.H., Vernazza, P., Eap, C.B. and Telenti, A. (2002) "Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study", Lancet 359, 30-36.
71. Dresher, S., Schaeffeler, E., Hitzl, M., Hofmann, U., Shwab, M., Brinkman, U., Eichelbaum, M. and Fromm, M.F. (2002) "MDR1 gene polymorphism and disposition of the P-glycoprotein substrate fexofenadine", Br. J. Clin. Pharmacol. 53, 526-534.
72. van den Heuvel-Eibrink, M.M., van Schaik, R.H.N., van der Heiden, I., Sonneveld, P., Pieters, R. and Wiemer, E.A.C. (2002) " MDR-1 Gene Polymorphisms G2677T and C3435T Do Not Correlate with P-Glycoprotein Expression and Function in Acute Myeloid Leukemia (AML ", Blood 98, 308a.
73. Efferth, T., Sauerbrey, A., Steinbach, D., Gebhart, E., Drexler, H.G., Miyachi, H., Chitambar, C.R., Becker, C.M., Zintl, F. and Humeny, A. (2003) "Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia", Int. J. Oncol. 23, 509-517.
74. Nakamura, T., Sakaeda, T., Horinouchi, M., Tamura, T., Aoyama, N., Shirakawa, T., Matsuo, M., Kasuga, M. and Okumura, K. (2002) "Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects", Clin. Pharmacol. Ther. 71, 297-303.
75. Goto, M., Masuda, S., Saito, H., Uemoto, S., Kiuchi, T., Tanaka, K. and Inui, K. (2002) "C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than P-gp in recipients of living-donor liver transplantation", Pharmacogenetics 12, 451-454.
76. Siegsmund, M., Brinkmann, U., Schaffeler, E., Weirich, G., Schwab, M., Eichelbaum, M., Fritz, P., Burk, O., Decker, J., Alken, P., Rothenpieler, U., Kerb, R., Hoffmeyer, S. and Brauch, H. (2002) "Association of the P-glycoprotein transporter MDR1 (C3435T) polymorphism with the susceptibility to renal epithelial tumors", J. Am. Soc. Nephrol. 13, 1847-1854.
77. Verstuyft, C., Schwab, M., Schaeffeler, E., Kerb, R., Brinkmann, U., Jaillon, P., Funck-Brentano, C. and Becquemont, L. (2003) "Digoxin pharmacogenetics and MDR1 genetic polymorphisms", Eur. J. Clin. Pharmacol. 58, 809-812.
78. Sakaeda, T., Nakamura, T., Horinouchi, M., Kakumoto, M., Ohmoto, N., Sakai, T., Morita, Y., Tamura, T., Aoyama, N., Hirai, M., Kasuga, M. and Okumura, K. (2001) "MDR1 genotype-related pharmacogenetics of digoxin after single oral administration in healthy Japanese subjects", Pharmacol. Res. 18, 1400-1404.
79. Morita, Y., Sakaeda, T., Horinouchi, M., Nakamura, T., Kuroda, K., Miki, I., Yoshimura, K., Sakai, T., Shirasaka, D., Tamura, T., Aoyama, N., Kasuga, M. and Okumura, K. (2003) "MDR1 genotype-related duodenal absorption rate of digoxin in healthy Japanese subjects", Pharm. Res. 20, 552-556.
80. Anglicheau, D., Verstuyft, C., Laurent-Puig, P., Becquemont, L., Schlageter, M.H., Cassinat, B., Beaune, P., Legendre, C. and Thervet, E. (2003) "Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients", J. Am. Soc. Nephrol. 14, 1889-1896.
81. Yates, C.R., Zhang, W., Song, P., Li, S., Gaber, A.O., Kotb, M., Honaker, M.R., Alloway, R.R. and Meibohm, B. (2003) "The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patients", J. Clin. Pharmacol. 43, 555-564.
82. Siegmund, W., Ludwig, K., Giessmann, T., Dazert, P., Schroeder, E., Sperker, B., Warzok, R., Kroemer, H.K. and Cascorbi, I. (2002) "The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol" , Clin. Pharmacol. Ther. 72, 572-583.
83. von Ahsen, N., Richter, M., Grupp, C., Ringe, B., Oellerich, M. and Armstrong, V.W. (2001) "No influence of MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V Allele) on dose-adjusted cyclosporine A trough concentrations or rejection incidence in stable renal transplant recipients", Clin. Chem. 47, 1048-1052.
84. Min, D.I. and Ellingrod, V.L. (2002) "C3435T mutation in exon 26 of the human MDR1 gene and cyclosporine pharmacokinetics in healthy subjects", Ther. Drug Monit. 24, 400-404.
85. Kerb, R., Aynacioglu, A.S., Brockmoller, J., Schlagenhaufer, R., Bauer, S., Szekeres, T., Hamwi, A., Fritzer-Szekeres, M., Baumgartner, C., Ongen, H.Z., Guzelbey, P., Roots, I. and Brinkmann, U. (2001) "The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels", Pharmacogenomics J. 1, 204-210.
86. Drescher, S., Schaeffeler, E., Hitzl, M., Hofmann, U., Schwab, M., Brinkmann, U., Eichelbaum, M. and Fromm, M.F. (2002) " MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine", Br. J. Clin. Pharmacol. 53, 526-534.
87. Kimchi-Sarfaty, C., Gribar, J.J. and Gottesman, M.M. (2002) "Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system", Mol. Pharmacol. 62, 1-6.
88. Morita, N., Yasumori, T. and Nakayama, K. (2003) "Human MDR1 polymorphism: G2677T/A and C3435T have no effect on MDR1 transport activities", Biochem. Pharmacol. 65, 1843-1852.
89. Potocnik, U., Ravnik-Glavac, M. and Glavac, D. (2002) "Functional MDR1 polymorphisms (G2677T and C3435T) and TCF4 mutations in colorectal tumors with high microsatellite instability" , Cell Mol. Biol. Lett. 7, 92-95.
90. Schwab, M., Schaeffeler, E., Marx, C., Fromm, M.F., Kaskas, B., Metzler, J., Stange, E., Herfarth, H., Schoelmerich, J., Gregor, M., Walker, S., Cascorbi, I., Roots, I., Brinkmann, U., Zanger, U.M. and Eichelbaum, M. (2003) "Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis", Gastroenterology 124, 26-33.
91. Calado, R.T., Falcao, R.P., Garcia, A.B., Gabellini, S.M., Zago, M.A. and Franco, R.F. (2002) "Influence of functional MDR1 gene polymorphisms on P-glycoprotein activity in CD34+ hematopoietic stem cells", Haematologica 87, 564-568.
92. Rund, D., Azar, I. and Shperling, O. (1999) "A mutation in the promoter of the multidrug resistance gene (MDR1) in human hematological malignancies may contribute to the pathogenesis of resistant disease", Adv. Exp. Med. Biol. 457, 71-75.
93. Calado, R.T., Franco, R.F., Zago, M.A. and Falcao, R.P. (2002) "MDR1 gene C3435T polymorphism and the risk of acquired aplastic anaemia", Br. J. Haematol. 117, 769.
94. Ben-Yehuda, D., Krichevsky, S., Shafran, S., Bar Cohen, S., Goldschmidt, N., Kedmi, M., Ben Neriah, S. and Rund, D. (2002) "Therapy-Related Leukemia: Clinical Characteristics and Analysis of New Molecular Risk Factors in 96 Patients", Blood 100, 324a.
95. Urayama, K.Y., Wiencke, J.K., Buffler, P.L. and Wiemels, J.L. (2002) "The role of MDR1 gene polymorphisms in the genetic susceptibility to childhood leukemia", Ann. Epidemiol. 12, 497.
96. van den Heuvel-Eibrink, M.M., Wiemer, E.A., de Boevere, M.J., van der Holt, B., Vossebeld, P.J., Pieters, R. and Sonneveld, P. (2001) "MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia", Blood 97, 3605-3611.
97. Stanulla, M., Schaeffeler, E., Schrappe, M., Rathmann, A., Arens, S., Welte, K., Eichelbaum, M., Zanger, U. and Schwab, M. (2001) "An Association between the MDR1 C3435T Polymorphism and CNS Relapse in Childhood Acute Lymphoblastic Leukemia", Blood 98, 316a.
98. Kafka, A., Sauer, G., Jaeger, C., Grundmann, R., Kreienberg, R., Zeillinger, R. and Deissler, H. (2003) "Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer", Int. J. Oncol. 22, 1117-1121.
99. Furuno, T., Landi, M.T., Ceroni, M., Caporaso, N., Bernucci, I., Nappi, G., Martignoni, E., Schaeffeler, E., Eichelbaum, M., Schwab, M. and Zanger, U.M. (2002) "Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease", Pharmacogenetics 12, 529-534.
100. Drozdzik, M., Bialecka, M., Mysliwiec, K., Honczarenko, K., Stankiewicz, J. and Sych, Z. (2003) "Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease", Pharmacogenetics 13, 259-263.
101. Roberts, R.L., Joyce, P.R., Mulder, R.T., Begg, E.J. and Kennedy, M.A. (2002) "A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression", Pharmacogenomics J. 2, 191-196.
102. Nasi, M., Borghi, V., Pinti, M., Bellodi, C., Lugli, E., Maffei, S., Troiano, L., Richeldi, L., Mussini, C., Esposito, R. and Cossarizza, A. (2003) "MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV positive patients", AIDS 17, 1696-1698.
103. Ifergan, I., Bernard, N.F., Bruneau, J., Alary, M., Tsoukas, C.M. and Roger, M. (2002) "Allele frequency of three functionally active polymorphisms of the MDR-1 gene in high-risk HIV-negative and HIV-positive Caucasians", AIDS 16, 2340-2342.
104. Zheng, H., Webber, S., Zeevi, A., Schuetz, E., Zhang, J., Bowman, P., Boyle, G., Law, Y., Miller, S., Lamba, J. and Burckart, G.J. (2003) "Tacrolimus Dosing in Pediatric Heart Transplant Patients is Related to CYP3A5 and MDR1 Gene Polymorphisms", Am. J. Transplant. 3, 477-483.
105. Gwee, P.C., Tang, K., Chua, J.M., Lee, E.J., Chong, S.S. and Lee, C.G. (2003) "Simultaneous genotyping of seven single-nucleotide polymorphisms in the MDR1 gene by single-tube multiplex minisequencing", Clin. Chem. 49, 672-676.
106. Song, P., Li, S., Meibohm, B., Gaber, A.O., Honaker, M.R., Kotb, M. and Yates, C.R. (2002) "Detection of MDR1 single nucleotide polymorphisms C3435T and G2677T using real-time polymerase chain reaction: MDR1 single nucleotide polymorphism genotyping assay", AAPS PharmSci. 4, 29.
107. Nauck, M., Stein, U., von Karger, S., Marz, W. and Wieland, H. (2000) "Rapid detection of the C3435T polymorphism of multidrug resistance gene 1 using fluorogenic hybridization probes", Clin. Chem. 46, 1995-1997.
108. Evans, W.E., Relling, M.V., Rodman, J.H., Crom, W.R., Boyett, J.M. and Pui, C.H. (1998) "Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia", N. Engl. J. Med. 338, 499-505.